Association between FTO polymorphism and COVID-19 mortality among older adults: A population-based cohort study
| Authors | |
|---|---|
| Year of publication | 2024 |
| Type | Article in Periodical |
| Magazine / Source | INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES |
| MU Faculty or unit | |
| Citation | |
| Web | https://www.sciencedirect.com/science/article/pii/S1201971224003035?via%3Dihub |
| Doi | http://dx.doi.org/10.1016/j.ijid.2024.107232 |
| Keywords | COVID-19; SARS-CoV-2FTO; Mortality; Polymorphism |
| Attached files | |
| Description | COVID-19 caused a global pandemic with millions of deaths. Fat mass and obesity-associated gene (FTO) (alias m6A RNA demethylase) and its functional rs17817449 polymorphism are candidates to influence COVID-19-associated mortality since methylation status of viral nucleic acids is an important factor influencing viral viability. We tested a population-based cohort of 5233 subjects (aged 63-87 years in 2020) where 70 persons died from COVID-19 and 394 from other causes during the pandemic period. The frequency of GG homozygotes was higher among those who died from COVID-19 (34%) than among survivors (19%) or deaths from other causes (20%), P <0.005. After multiple adjustments, GG homozygotes had a higher risk of death from COVID-19 with odds ratio = 2.01 (95% confidence interval; 1.19-3.41, P <0.01) compared with carriers of at least one T allele. The FTO polymorphism was not associated with mortality from other causes. Our results suggest that FTO variability is a significant predictor of COVID-19-associated mortality in Caucasians. |
| Related projects: |